Overview

AD816 Crossover Study

Status:
Not yet recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.
Phase:
Phase 2
Details
Lead Sponsor:
Apnimed